Prescription drug costs
Prescription costs for people with Medicare changed shape in 2025, when Part D gained an annual out-of-pocket cap and an optional way to pay that spending in monthly installments instead of at the counter. The cap rises each year by a formula CMS publishes in its annual rate announcement, and the deductible moves with it. For 2027 both figures are already set, which makes open enrollment the right time to work through what a year of prescriptions would cost under each plan you are considering.
The guides in this section explain those mechanics: what counts toward the cap, how the monthly payment plan calculates each bill, and what happens if a payment is missed. They use the CMS and Medicare.gov figures with their dates and labeled example drug costs, never a recommendation about any drug.
MyCarePrice does not comment on which medication anyone should take or switch to. Questions about a drug belong with the prescriber or pharmacist; questions about a plan's formulary and cost sharing belong with the plan, ideally answered in writing.
The numbers for 2027 are set: a deductible of no more than $700 and an out-of-pocket ceiling of $2,400 for covered Part D drugs, up from $615 and $2,100 in 2026, according to CMS. Medicare open enrollment runs October 15 to December 7, with new coverage from January 1. Those two facts make the autumn the time to estimate a year of drug costs under each plan you are considering, check that every drug is covered, and decide whether spreading the spending over monthly bills would help your budget. The guides below show the arithmetic with labeled example costs.
Keep the plan's monthly statements through the year. They report the running total that counts toward the cap, which is the figure to check if a pharmacy charge or a payment-plan bill looks wrong, and the record to bring to the plan when it does. People who qualify for Extra Help have their own, lower cost sharing, and CMS says that program is more advantageous for them than the monthly payment option.
Not every prescription runs through a plan. A pharmacy discount card can show a lower price at the counter, but Medicare.gov says a card purchase made instead of your Medicare plan does not count toward the deductible or the out-of-pocket maximum, and a commercial plan counts it only if its own rules allow. The discount card guide below works through that trade with a stated example, explains the federal laws that let a pharmacist tell you when the cash price is lower, and sets brand and generic acquisition costs side by side from the CMS NADAC file, which records what pharmacies paid, not what patients pay.
Medicare Part D out-of-pocket cap
The yearly ceiling on covered drug costs, what counts toward it, and the month a steady prescription bill reaches it.
Medicare Prescription Payment Plan
How the optional monthly billing spreads pharmacy costs, the formula behind each month's bill, and what a late start changes.
Do drug discount cards count toward your deductible?
When a card price beats your plan price, what the purchase does to your deductible and Part D cap, the federal gag-clause laws, and what pharmacies pay for brand against generic.
Medicare Part B infusion drug coinsurance
Original Medicare charges 20 percent of the ASP plus 6 percent payment limit on infused drugs, with no yearly cap. Q4 2026 limits for common J-codes, yearly totals against the Part D cap, the IRA reduced-coinsurance list, and how Medigap and the MA MOOP close the gap.
Medicare CGM cost per month
Your share of a Medicare CGM is 20 percent of the monthly A4239 supply allowance. October 2026 amounts with and without KF, the E2103 receiver, yearly totals and the coming bundled rental.
Part D late enrollment penalty per month
The penalty for 1 to 120 uncovered months at the 2026 and 2027 base premiums, why 63 days and full months are different clocks, how Extra Help and the CMS reconsideration change the count, and a 30-month lifetime example.
Adult vaccine prices versus the Medicare payment limit
The CDC private-sector price for 22 adult vaccines beside the Part B payment limit, the Part D zero-cost rule and the administration line.
Eye injection cost per shot: aflibercept, ranibizumab, bevacizumab
October 2026 Medicare payment limits for nine eye-injection drug codes, your 20 percent per shot and per year, the 67028 administration line, and nine quarters showing biosimilar limits above their reference product.